Zhang Zhen, Zhao Hong, Chu Chu, Fu Xiaoxiao, Liu Yonglin, Wang Li, Wei Ran, Xu Ke, Li Lihua, Li Xia
Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
School of Clinical and Basic Medicine, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Front Pharmacol. 2022 Dec 16;13:1072670. doi: 10.3389/fphar.2022.1072670. eCollection 2022.
Ovarian cancer is fatal to women and has a high mortality rate. Although on-going efforts are never stopped in identifying diagnostic and intervention strategies, the disease is so far unable to be well managed. The most important reason for this is the complexity of pathogenesis for OC, and therefore, uncovering the essential molecular biomarkers accompanied with OC progression takes the privilege for OC remission. Inflammation has been reported to participate in the initiation and progression of OC. Both microenvironmental and tumor cell intrinsic inflammatory signals contribute to the malignancy of OC. Inflammation responses can be triggered by various kinds of stimulus, including endogenous damages and exogenous pathogens, which are initially recognized and orchestrated by a series of innate immune system related receptors, especially Toll like receptors, and cyclic GMP-AMP synthase. In this review, we will discuss the roles of innate immune system related receptors, including TLRs and cGAS, and responses both intrinsic and exogenetic in the development and treatment of OC.
卵巢癌对女性来说是致命的,死亡率很高。尽管在确定诊断和干预策略方面的努力从未停止,但迄今为止,这种疾病仍无法得到有效控制。造成这种情况的最重要原因是卵巢癌发病机制的复杂性,因此,揭示伴随卵巢癌进展的关键分子生物标志物对于卵巢癌的缓解至关重要。据报道,炎症参与了卵巢癌的发生和发展。微环境和肿瘤细胞内在的炎症信号都促成了卵巢癌的恶性发展。炎症反应可由各种刺激引发,包括内源性损伤和外源性病原体,这些刺激最初由一系列与先天免疫系统相关的受体识别和协调,尤其是Toll样受体和环状GMP-AMP合酶。在这篇综述中,我们将讨论先天免疫系统相关受体,包括Toll样受体和环状GMP-AMP合酶的作用,以及内在和外在反应在卵巢癌发生发展和治疗中的作用。